Pyridoxal-5'-phosphate (PLP) plays a central role as a cofactor of many enzymes of amino acid metabolism. In addition, the presence of the vitamin derivative has been demonstrated in rabbit skeletal muscle phosphorylase,'-3 where it was shown to be linked to the protein moiety as a substituted aldamine derivative (Fig. 1, I ) at neutral pH values and as an easily dissociable Schiff base (II) in the acid range.-In order to prove the proposed structures and to unequivocally determine the group involved in the binding of the vitamin B6 derivative, a new method was derived by which the imine double bond of the Schiff base was reduced by sodium borohydride to yield a substituted amine (IV) which was presumed to be stable to acid and enzymic hydrolysis. When the method was applied to muscle phosphorylase a, the four-PLP residues present were found to be linked to the -amino group of a unique lysine in each of the four subunits of the enzyme.4 A tripeptide6 was also isolated following chymotryptic attack, having the sequence of e-N-pyridoxyllysyl. Lysyl. Phenylalanine. Furthermore, although Cori and Illingworth2 have shown that removal of PLP from phosphorylase is accompanied by a total loss of enzymic activity, the NaBH4-reduced enzyme was found to be essentially fully active. This was taken to strongly indicate that, during the reduction, no transfer of PLP had taken place and no gross changes in the architecture of the enzyme had occurred. The method therefore appeared to be a valid one for determining the site of binding of PLP to the protein moiety of phosphorylase a and, by extension, to other enzymes, thereby providing a unique tool for comparing the nature of the "active sites" of PLP-proteins with quite different catalytic properties. A preliminary study of the site of binding of PLP in cystathionase (work done in collaboration with D. M. Greenberg) and glutamic-aspartic transaminase indicated that both these enzymes contained e-pyridoxyllysine after reduction.6 Recently, Fasella and co-workers' confirmed this latter finding in a preliminary publication describing the isolation of a peptide containing e-pyridoxyllysine after chymotryptic degradation of glutamic-aspartic transaminase reduced according to the above procedure. The purpose of the present report is to describe the properties of a pure peptide containing covalently bound PLP isolated from reduced glutamicaspartic transaminase after exhaustive attack with chymotrypsin.
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Reduction of the Enzyme with Sodium Borohydride.-Glutamic-aspartic transaminase was prepared by the method of Jenkins, Yphantis, and Sizer8 and was approximately 70 per cent pure, as indicated by ultracentrifugation, and electrophoretic and spectroscopic studies. At pH 4.8, the active enzyme shows a main adsorption peak at 430 mA and a subsidiary peak at 335 mj. (Fig. 2 , curve A). Glutamic-aspartic transaminase (870 mg corresponding to 5 jtmoles of enzyme and 10 imoles of PLP) dissolved in 0.1 M acetate buffer, pH 4.8 (30 ml) was treated at 00 with sodium borohydride (25 mg). The mixing was carried out in a centrifuge tube, which, immediately after addition of the borohydride, was centrifuged at low (B) reduction with sodium borohydride.
idues in the reduced enzyme after extensive dialysis, using the dichloroquinone-chloroimide reagent,9 and pyridoxamine-5'-phosphate as a standard.
Denaturation and Proteolytic Attack of the Reduced Enzyme.-After dialysis, solid urea was added to the reduced enzyme with stirring at 00 to give a final concentration of 10 M. The flask was warmed to room temperature, ,3-mercaptoethanol (0.10 ml) added, and the solution kept at room temperature (250 C) under nitrogen for four hr. After this time, neutral iodoacetate (1.4 gm dissolved in 10 ml water) was added and the reaction allowed to proceed for 10 min. 10 The solution was thentransferred to a dialysis bag and dialyzed extensively against cold 0.05 M TRISHCl buffer, pH 8.5, to remove excess reagents. Under these conditions, the protein remains soluble. Chymotrypsin (50 mg, Worthington, thrice crystallized) was then added and the mixture incubated at 37°. Portions of the digest were withdrawn at intervals and the extent of proteolysis was determined with the ninhydrin reagent." The reaction was complete after 24 hr. The mixture was brought to pH 2.1 by addition of 50 per cent TCA, and the precipitated protein was removed on the centrifuge. The dried residue was approximately 15 per cent by weight of total protein. The supernatant containing 8 Jemoles of equivalent PMP (80% of total) was fractionated on DOWEX-50 (X2) resin, as described by Hirs, et al. 12 and the emergence of pyridoxyl-containing material was followed by adsorption at 330 mu and by measurement of fluorescence, using the Farrand spectrofluorometer at 400 my4 at an excitation wavelength of 335 my. Only one peak, emerging from the column at pH 4.6, was detected by these methods (Fig. 3) fractions were pooled, salts were removed by the method of Haugaard and Haugaard" and the salt-free solution was lyophilized. The pyridoxyl-derivative was examined and further purified by paper chromatography and by high-voltage electrophoresis. Detection of pyridoxyl-peptide was greatly facilitated by the intense, blue fluorescence exhibited by these compounds under ultraviolet light. Only one fluorescent band could be detected after paper chromatography in butanol: acetic acid: water (4:1:5) and electrophoresis in pyridine-acetate buffers, pH 3.6 and 6.5.14 The purified pyridoxyl-peptide was subjected to hydrolysis in 5.7 N HCl at 1100 for 20 hr; e-pyridoxyllysine was identified by paper chromatography and electrophoresis by comparison with an authentic sample."5 Quantitative amino acid analysis on the Beckman/Spinco auto-analyzer indicated the peptide to have the composition: Ser2, Glu2, Asp2, Thr, Gly, Ala, Val, Ileu, Phe, Lys, e-pyridoxyllysine. Carboxypeptidase A released at successively decreasing rates phenylalanine, aspartic acid, serine, and glycine, enabling the carboxylterminal tetrapeptide sequence to be identified as Gly. Ser. Asp. Phe. After reaction with fluorodinitrobenzene,'6 DNP-serine was identified as the sole ethersoluble derivative in total acid hydrolyzates of the dinitrophenylated peptide.
Further sequential analysis of the peptide, using the Edman reagent,'6 indicated the amino-terminal sequence to be Ser. Thr. Glu. A partial structure for the pyridoxylpeptide is therefore: Ser. Thr. Glu. (Asp, Gly, Ala, Val, Ileu, e-pyridoxyllys, Lys,)
Gly. Ser. Asp. Phe.
As mentioned previously, the chymotryptic tripeptide, e-pyridoxyllys. Lys.
Phe., has been isolated from sodium borohydride-reduced phosphorylase a.5 Al-though neither the lysyl nor e-pyridoxyllysyl residues have been placed in the peptide isolated from glutamic-aspartic transaminase, it can be seen that this tripeptide sequence cannot be present since the carboxyl-terminal arrangement containing the only phenylalanyl residue of the peptide has been established and contains neither residue. The possibility that in both peptides the lysyl and epyridoxyllysyl residues occur in adjacent positions remains to be determined.
It is further interesting that neither peptide contains a cysteinyl residue in the vicinity of the substituted lysyl group. This, of course, does not eliminate the possibility that a sulfhydryl group is involved in forming the substituted aldamine structure which probably exists to some extent in most of these enzymes. If this should be the case, however, it would imply that the cysteinyl residue is either far removed on the same polypeptide or even located on separate chains. That other groups are responsible for forming this structure, e.g., the e-amino group of the second lysyl residue of PLP-peptides isolated from both phosphorylase a and glutamic-aspartic transaminase, represents a distinct possibility. In summary, a tetradecapeptide containing covalently bound pyridoxyl-5'-phosphate has been isolated from pig heart glutamic-aspartic transaminase after reduction with sodium borohydride and subsequent degradation with chymotrypsin. A partial structure for the peptide has been shown to be: Ser. Thr. Glu. (Asp, Gly, Ala, Val, Ileu, e-pyridoxyllys, Lys,) Gly. Ser. Asp. Phe. The significance of the results, together with similar information as to the site of binding of the vitamin derivative to muscle phosphorylase a, is discussed.
